Bliss GVS Pharma Limited Share Price & Analysis
₹276.9▲ +1.13%Updated 13 May 2026, 11:32 am IST
LTP
₹276.9
+1.13%
Open
₹—
High
₹285
Low
₹268.55
Close
₹276.9
52W High
₹281
52W Low
₹114
Volume
2432K
Lot Size
1
Sector
Healthcare
Market Cap
₹3K Cr
Face Value
₹1
Small Cap
Price Chart
Fundamentals
P/E
25.8
Sector P/E
43.5
P/B
2.59
EPS
₹10.33
ROE
8.36%
ROCE
11.7%
D/E Ratio
0.05
Div Yield
0.19%
Book Value
₹107
+
Strengths
- ✓Attractively valued vs sector (P/E 25.8x vs industry 43.5x)
- ✓Virtually debt-free
−
Concerns
- ✗Trading near 52-week high (₹281)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,844 | ₹4.4L Cr | 36.5 | 5.69 | 16.9 | 20.2 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹6,711 | ₹1.8L Cr | 70.3 | 11.55 | 15.4 | 20.4 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,358 | ₹1.5L Cr | 64.3 | 17.43 | 26.5 | 27 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,057 | ₹1.2L Cr | 64.1 | 12.75 | 18.4 | 16.6 | 0.88 |
| CIPLA Cipla Limited | ₹1,306 | ₹1.1L Cr | 22.9 | 3.2 | 17.8 | 22.7 | 0.01 |
| LUPIN Lupin Limited | ₹2,238 | ₹1.1L Cr | 18.9 | 4.56 | 29.1 | 30.3 | 0.32 |
| DRREDDY Dr. Reddy's Laboratories Limited | ₹1,274 | ₹1.1L Cr | 19.4 | 2.95 | 18 | 22.7 | 0.16 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
BLISSGVS · as of Mar 2026
Promoters35.29%▲0.19
FII13.18%▼0.33
DII6.55%
Public44.98%▲0.14
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 34.97% | 34.97% | 34.90% | 34.82% | 35.10% | 35.29% |
| FII | 15.35% | 14.74% | 13.24% | 12.13% | 13.51% | 13.18% |
| DII | 6.60% | 6.59% | 6.58% | 6.56% | 6.55% | 6.55% |
| Public | 43.08% | 43.71% | 45.27% | 46.49% | 44.84% | 44.98% |
Corporate Events
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
Dividend11 May 2026
Interim Dividend - Re 0.50 Per Share
Dividend17 Feb 2026
Annual General Meeting/Dividend - Rs 0.50 Per Share
Dividend23 Jul 2025
Annual General Meeting/Dividend - Rs 0.50 Per Share
Dividend17 Jul 2024
Annual General Meeting/Dividend - Re 0.50 Per Share
Dividend11 Jul 2023
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹218 Cr ▼10.7% | ₹244 Cr ▲17.9% | ₹207 Cr ▲4.5% | ₹198 Cr ▼5.7% | ₹210 Cr ▼3.7% | ₹218 Cr ▲18.5% | ₹184 Cr ▼7.1% | ₹198 Cr |
| Op. Profit | ₹35 Cr ▼18.6% | ₹43 Cr ▲4.9% | ₹41 Cr ▲95.2% | ₹21 Cr ▼30.0% | ₹30 Cr ▼26.8% | ₹41 Cr ▲20.6% | ₹34 Cr ▲21.4% | ₹28 Cr |
| OPM | 16.0% ▼11.1% | 18.0% ▼10.0% | 20.0% ▲81.8% | 11.0% ▼21.4% | 14.0% ▼26.3% | 19.0% ▲0.0% | 19.0% ▲35.7% | 14.0% |
| Net Profit | ₹25 Cr ▼13.8% | ₹29 Cr ▼34.1% | ₹44 Cr ▲158.8% | ₹17 Cr ▼34.6% | ₹26 Cr ▲0.0% | ₹26 Cr ▲18.2% | ₹22 Cr ▲540.0% | ₹-5 Cr |
| EPS (₹) | 2.2 ▼14.7% | 2.58 ▼36.8% | 4.08 ▲177.6% | 1.47 ▼35.0% | 2.26 ▼2.2% | 2.31 ▲17.3% | 1.97 ▲326.4% | -0.87 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹810 Cr ▲5.2% | ₹770 Cr ▲2.4% | ₹752 Cr ▲0.7% | ₹747 Cr ▲29.5% | ₹577 Cr ▼16.3% | ₹689 Cr ▼23.4% | ₹899 Cr ▲10.3% | ₹815 Cr ▲2.1% | ₹798 Cr |
| Expenses | ₹683 Cr ▲10.2% | ₹620 Cr ▼2.2% | ₹634 Cr ▲0.8% | ₹629 Cr ▲33.5% | ₹471 Cr ▼16.8% | ₹566 Cr ▼23.4% | ₹739 Cr ▲19.6% | ₹618 Cr ▲3.7% | ₹596 Cr |
| Op. Profit | ₹127 Cr ▼15.9% | ₹151 Cr ▲29.1% | ₹117 Cr ▼0.8% | ₹118 Cr ▲10.3% | ₹107 Cr ▼13.0% | ₹123 Cr ▼23.1% | ₹160 Cr ▼18.8% | ₹197 Cr ▼3.0% | ₹203 Cr |
| OPM | 16.0% ▼20.0% | 20.0% ▲25.0% | 16.0% ▲0.0% | 16.0% ▼11.1% | 18.0% ▲0.0% | 18.0% ▲0.0% | 18.0% ▼25.0% | 24.0% ▼4.0% | 25.0% |
| Other Income | ₹36 Cr | ₹0 Cr ▼100.0% | ₹18 Cr ▲142.9% | ₹-42 Cr ▼310.0% | ₹20 Cr ▼23.1% | ₹26 Cr ▼25.7% | ₹35 Cr ▲537.5% | ₹-8 Cr ▼166.7% | ₹12 Cr |
| Interest | ₹8 Cr ▲14.3% | ₹7 Cr ▼30.0% | ₹10 Cr ▲100.0% | ₹5 Cr ▼16.7% | ₹6 Cr ▼25.0% | ₹8 Cr ▲100.0% | ₹4 Cr ▼82.6% | ₹23 Cr ▲15.0% | ₹20 Cr |
| Depreciation | ₹29 Cr ▲11.5% | ₹26 Cr ▲36.8% | ₹19 Cr ▲11.8% | ₹17 Cr ▲0.0% | ₹17 Cr ▲30.8% | ₹13 Cr ▲44.4% | ₹9 Cr ▼57.1% | ₹21 Cr ▲5.0% | ₹20 Cr |
| PBT | ₹126 Cr ▲7.7% | ₹117 Cr ▲10.4% | ₹106 Cr ▲96.3% | ₹54 Cr ▼48.1% | ₹104 Cr ▼19.4% | ₹129 Cr ▼29.1% | ₹182 Cr ▲25.5% | ₹145 Cr ▼17.1% | ₹175 Cr |
| Tax % | 28.0% ▼6.7% | 30.0% ▲7.1% | 28.0% ▼50.9% | 57.0% ▲96.6% | 29.0% ▲11.5% | 26.0% ▼13.3% | 30.0% ▼23.1% | 39.0% ▲8.3% | 36.0% |
| Net Profit | ₹90 Cr ▲9.8% | ₹82 Cr ▲6.5% | ₹77 Cr ▲234.8% | ₹23 Cr ▼68.9% | ₹74 Cr ▼22.1% | ₹95 Cr ▼25.2% | ₹127 Cr ▲42.7% | ₹89 Cr ▼21.2% | ₹113 Cr |
| EPS (₹) | 8 ▲11.0% | 7.21 ▲6.0% | 6.8 ▲369.0% | 1.45 ▼78.2% | 6.64 ▼29.6% | 9.43 ▼21.4% | 11.99 ▲110.4% | 5.7 ▼28.3% | 7.95 |
| Div Payout | 6.0% ▼14.3% | 7.0% ▲0.0% | 7.0% ▼79.4% | 34.0% ▲325.0% | 8.0% ▲60.0% | 5.0% ▼37.5% | 8.0% ▼55.6% | 18.0% ▲125.0% | 8.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹11 Cr ▲0.0% | ₹11 Cr ▲10.0% | ₹10 Cr ▲0.0% | ₹10 Cr ▲0.0% | ₹10 Cr ▲0.0% | ₹10 Cr ▲0.0% | ₹10 Cr ▲0.0% | ₹10 Cr ▲0.0% | ₹10 Cr ▲0.0% | ₹10 Cr |
| Reserves | ₹1.1K Cr ▲7.9% | ₹1.0K Cr ▲8.7% | ₹957 Cr ▲9.6% | ₹873 Cr ▲8.0% | ₹808 Cr ▲1.3% | ₹798 Cr ▲10.1% | ₹725 Cr ▲14.0% | ₹636 Cr ▲20.9% | ₹526 Cr ▲10.5% | ₹476 Cr |
| Borrowings | ₹52 Cr ▼40.9% | ₹88 Cr ▼12.0% | ₹100 Cr ▼2.0% | ₹102 Cr ▼6.4% | ₹109 Cr ▼10.7% | ₹122 Cr ▼3.2% | ₹126 Cr ▲23.5% | ₹102 Cr ▼13.6% | ₹118 Cr ▼47.6% | ₹225 Cr |
| Other Liabilities | ₹215 Cr ▲32.7% | ₹162 Cr ▲11.7% | ₹145 Cr ▼15.2% | ₹171 Cr ▼5.5% | ₹181 Cr ▲23.1% | ₹147 Cr ▼12.5% | ₹168 Cr ▲7.0% | ₹157 Cr ▼23.8% | ₹206 Cr ▼33.8% | ₹311 Cr |
| Total Liabilities | ₹1.4K Cr ▲7.6% | ₹1.3K Cr ▲7.3% | ₹1.2K Cr ▲4.8% | ₹1.2K Cr ▲4.3% | ₹1.1K Cr ▲3.0% | ₹1.1K Cr ▲4.6% | ₹1.0K Cr ▲13.8% | ₹905 Cr ▲5.2% | ₹860 Cr ▼15.9% | ₹1.0K Cr |
| Assets | ||||||||||
| Fixed Assets | ₹392 Cr ▼3.4% | ₹406 Cr ▲9.7% | ₹370 Cr ▼2.4% | ₹379 Cr ▲34.9% | ₹281 Cr ▲20.1% | ₹234 Cr ▼3.3% | ₹242 Cr ▲65.8% | ₹146 Cr ▲2.1% | ₹143 Cr ▼53.1% | ₹305 Cr |
| CWIP | ₹39 Cr ▲85.7% | ₹21 Cr ▲162.5% | ₹8 Cr ▲166.7% | ₹3 Cr ▼86.4% | ₹22 Cr ▲1000.0% | ₹2 Cr | ₹0 Cr ▼100.0% | ₹47 Cr | ₹0 Cr ▼100.0% | ₹4 Cr |
| Investments | ₹10 Cr ▲150.0% | ₹4 Cr ▲0.0% | ₹4 Cr ▼50.0% | ₹8 Cr ▲300.0% | ₹2 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other Assets | ₹959 Cr ▲10.2% | ₹870 Cr ▲4.8% | ₹830 Cr ▲8.1% | ₹768 Cr ▼4.4% | ₹803 Cr ▼4.4% | ₹840 Cr ▲6.6% | ₹788 Cr ▲10.7% | ₹712 Cr ▼0.7% | ₹717 Cr ▲0.4% | ₹714 Cr |
| Total Assets | ₹1.4K Cr ▲7.6% | ₹1.3K Cr ▲7.3% | ₹1.2K Cr ▲4.8% | ₹1.2K Cr ▲4.3% | ₹1.1K Cr ▲3.0% | ₹1.1K Cr ▲4.6% | ₹1.0K Cr ▲13.8% | ₹905 Cr ▲5.2% | ₹860 Cr ▼15.9% | ₹1.0K Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹106 Cr ▲2.9% | ₹103 Cr ▲202.9% | ₹34 Cr ▼74.8% | ₹135 Cr ▲110.9% | ₹64 Cr ▲36.2% | ₹47 Cr ▲17.5% | ₹40 Cr ▲122.2% | ₹18 Cr ▼93.8% | ₹289 Cr ▲155.8% | ₹113 Cr |
| Investing CF | ₹-75 Cr ▲9.6% | ₹-83 Cr ▼1283.3% | ₹-6 Cr ▲94.2% | ₹-103 Cr ▼128.9% | ₹-45 Cr ▼12.5% | ₹-40 Cr ▲49.4% | ₹-79 Cr ▼264.6% | ₹48 Cr ▲119.3% | ₹-249 Cr ▼398.0% | ₹-50 Cr |
| Financing CF | ₹-30 Cr ▼42.9% | ₹-21 Cr ▲16.0% | ₹-25 Cr ▼4.2% | ₹-24 Cr ▼14.3% | ₹-21 Cr ▼250.0% | ₹-6 Cr ▼135.3% | ₹17 Cr ▲122.4% | ₹-76 Cr ▼660.0% | ₹-10 Cr ▲75.0% | ₹-40 Cr |
| Net Cash Flow | ₹0 Cr ▲100.0% | ₹-1 Cr ▼133.3% | ₹3 Cr ▼66.7% | ₹9 Cr ▲550.0% | ₹-2 Cr | ₹0 Cr ▲100.0% | ₹-22 Cr ▼120.0% | ₹-10 Cr ▼133.3% | ₹30 Cr ▲30.4% | ₹23 Cr |
| Free Cash Flow | ₹33 Cr ▼56.0% | ₹75 Cr ▲227.1% | ₹-59 Cr ▼193.7% | ₹63 Cr ▲14.5% | ₹55 Cr ▲558.3% | ₹-12 Cr ▼700.0% | ₹2 Cr ▲128.6% | ₹-7 Cr ▼103.8% | ₹186 Cr ▲84.2% | ₹101 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 198d ▲3.1% | 192d ▲2.7% | 187d ▼2.6% | 192d ▼34.5% | 293d ▲1.0% | 290d ▲55.1% | 187d ▲39.6% | 134d ▲15.5% | 116d ▼42.3% | 201d |
| Inventory Days | 111d ▼1.8% | 113d ▲20.2% | 94d ▼19.0% | 116d ▲5.5% | 110d ▲71.9% | 64d ▲39.1% | 46d ▼16.4% | 55d ▲10.0% | 50d ▼9.1% | 55d |
| Days Payable | 63d ▲8.6% | 58d ▼26.6% | 79d ▼8.1% | 86d ▲4.9% | 82d ▲9.3% | 75d ▲59.6% | 47d ▼14.5% | 55d ▼45.0% | 100d ▼34.6% | 153d |
| Cash Conv. Cycle | 246d ▼0.4% | 247d ▲22.3% | 202d ▼8.6% | 221d ▼31.2% | 321d ▲15.1% | 279d ▲50.0% | 186d ▲38.8% | 134d ▲100.0% | 67d ▼34.3% | 102d |
| Working Capital Days | 199d ▼3.9% | 207d ▲7.8% | 192d ▲7.3% | 179d ▼32.2% | 264d ▲13.8% | 232d ▲50.6% | 154d ▲14.1% | 135d ▲1450.0% | -10d ▼111.9% | 84d |
| ROCE | 12.0% ▼14.3% | 14.0% ▲16.7% | 12.0% ▼14.3% | 14.0% ▲16.7% | 12.0% ▼33.3% | 18.0% ▼30.8% | 26.0% ▼3.7% | 27.0% ▼6.9% | 29.0% ▼6.5% | 31.0% |
Source: Screener.in · Lower days = better efficiency
About Bliss GVS Pharma Limited
Incorporated in 1984, Bliss GVS Pharma Limited is engaged in manufacturing, marketing, trading and export of pharmaceutical formulations in the form of suppositories, pessaries, capsules, tablets, and syrups.
Healthcare · Pharmaceuticals & Biotechnology
Related Analysis
Frequently Asked Questions
What is Bliss GVS Pharma Limited share price today?▾
Bliss GVS Pharma Limited (BLISSGVS) is currently trading at ₹276.9 on NSE, up 1.13% as of the last market session. Prices update daily after market close on MarketNetra.
Is Bliss GVS Pharma Limited available in F&O (Futures & Options)?▾
Yes, Bliss GVS Pharma Limited (BLISSGVS) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Bliss GVS Pharma Limited 52-week high and low?▾
Bliss GVS Pharma Limited's 52-week high is ₹281 and the 52-week low is ₹114. The current price of ₹276.9 is 1.5% below the 52W high.
What is Bliss GVS Pharma Limited P/E ratio?▾
Bliss GVS Pharma Limited's current P/E ratio is 25.8. This indicates the market is paying ₹25.8 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Bliss GVS Pharma Limited options?▾
Bliss GVS Pharma Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade BLISSGVS options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.